High out-of-pocket costs can make lifesaving medications out of reach for millions of Americans with cardiovascular disease

Authored by newsroom.heart.org and submitted by mvea
image for High out-of-pocket costs can make lifesaving medications out of reach for millions of Americans with cardiovascular disease

One in 8 adults with common heart diseases skip medications, delay filling prescriptions or take less medication than prescribed because of concerns about cost.

Not taking medications as prescribed because of cost is 3 times more common in people under 65 years of age than in older people covered by Medicare.

Embargoed until 4 a.m. CT / 5 a.m. ET Monday, Nov. 25, 2019

DALLAS, Nov. 25, 2019 — One in 8 adults with common heart diseases and stroke skip taking medications, delay filling prescriptions or take lower doses than prescribed because of concerns about cost, according to new research published today in the American Heart Association’s journal Circulation.

“The out-of-pocket cost of medications is a huge issue for millions of high-risk patients with cardiovascular diseases such as heart attacks, stroke, angina and other conditions. When faced with the expenses of taking lifesaving medications as prescribed or not taking them because they are too costly, many choose not to take them," said Khurram Nasir, M.D., M.P.H., M.Sc., senior author of the study, chief of the division of cardiovascular prevention and wellness and co-director of the Center for Outcomes Research at Houston Methodist DeBakey Heart & Vascular Center in Texas.

Not taking pills at the dose or the interval prescribed, called medication non-compliance, is a known problem for people with cardiovascular diseases. It often means they need more expensive care later because they become sicker and are more likely to need care in an emergency room, be hospitalized or have more frequent doctor’s appointments.

“While non-compliance has several causes, in recent years the rising share of health care costs paid directly by patients has become a concern. We wanted to understand the scope of medication non-compliance due to costs,” said Nasir.

The investigators analyzed survey responses from 14,279 adults (average age 65, 44 % female) who took part in the National Health Interview Survey between 2013 and 2017. All had previously been diagnosed with coronary heart disease, heart-related chest pain, a heart attack or a stroke.

The researchers found that, during the previous year:

1 in 8 people with these common heart diseases (corresponding to nearly 2.2 million people nationwide) had not taken their medication as prescribed because of cost concerns;

Cost-related, medication non-compliance was 3 times more common in people under 65 years of age, with nearly 1 in 5 reporting cost-related non-compliance;

Among those under 65, larger proportions of women (1 in 4), patients from low-income families (1 in 3) and patients without health insurance (more than half) reported not taking their medications as prescribed in order to save money;

Race and level of education did not have a significant effect on the proportion of patients with cost-related non-compliance; and

People who did not take medications as prescribed due to cost concerns were 11 times more likely to request low-cost medication and 9 times more likely to use alternative, non-prescription therapies, compared to people who reported that financial concerns did not impact their decision.

“Patients should not be afraid to speak with their health care provider if they are not able to afford a prescribed medication since there are many lower-cost generic drugs which might also be effective for their condition,” said Nasir.

“As health care providers, we should also consider advocating for changes in national health care policy, such as capping out-of-pocket expenses for low-income families. We also need to recognize that out-of-pocket medical costs may have a cumulative effect on a patient’s family who may also have difficulty paying for housing, transportation and food. Health care providers can play an active role in working with our local health system and community financial assistance support programs to provide financial assistance and resources to those who need it the most,” Nasir added.

The study did not examine the specific medications patients were prescribed and which were more likely to result in cost-related non-compliance.

As an evidence-based patient advocacy organization dedicated to improving the cardiovascular health of all Americans, the American Heart Association has a unique role in advocating for treatments, including medicines that are available, affordable and accessible to patients. Our 2017 Presidential Advisory on the accessibility and affordability of prescription drugs and biologics lays out the principles that guide our engagement in pursuit of this goal.

Co-authors are Rohan Khera, M.D.; Javier Valero-Elizondo, M.D., M.P.H.; Sandeep R. Das, M.D., M.P.H.; Salim S. Virani, M.D., Ph.D.; Bita A. Kash, Ph.D., M.B.A.; James A. de Lemos, M.D.; and Harlan M. Krumholz, M.D., S.M. Author disclosures are in the manuscript.

The National Center for Advancing Translational Sciences supported the study.

Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the Association’s policy or position. The Association makes no representation or guarantee as to their accuracy or reliability. The Association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific Association programs and events. The Association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations and health insurance providers are available at https://www.heart.org/en/about-us/aha-financial-information.

The American Heart Association is a relentless force for a world of longer, healthier lives. We are dedicated to ensuring equitable health in all communities. Through collaboration with numerous organizations, and powered by millions of volunteers, we fund innovative research, advocate for the public’s health and share lifesaving resources. The Dallas-based organization has been a leading source of health information for nearly a century. Connect with us on heart.org, Facebook, Twitter or by calling 1-800-AHA-USA1.

For Media Inquiries and AHA/ASA Expert Perspective: 214-706-1173

appkat on November 25th, 2019 at 16:26 UTC »

This study could easily be about endocrine, gastroenterology, any other system disease and prescribed medications for those over 65 with chronic conditions! It's deplorable. Not all conditions are avoidable by lifestyle, I have an autoimmune disease that is identifiable on a specific portion of a chromosome. When it comes to a choice of mortgage or meds, I have to choose a place to live, though I may not live as long because I can't afford to take the meds as prescribed. Prescription drug insurance coverage is essentially a buy-down for med costs, the higher the premium, the lower the cost (Monthly premium about $40.00, one med costs over $300/month. Monthly premium over $100.00, that med costs $110/month). Paying the higher monthly premium doesn't bring the total cost down to affordability. Insurance and Pharmaceutical company execs don't care if their salaries and bonuses are blood money, for they have forgotten their sacred responsibility to fellow humans. I'm sorrier for them than myself.

NotObviouslyARobot on November 25th, 2019 at 15:12 UTC »

Let's stop using phrases like "Out of pocket costs." The specificity just caters to the pricing structure that perpetuates the inflated costs, and that structure is the problem. Just say "High priced medications."

You've got to change the reimbursement system to stop the game of exploiting Medicare/Medicaid/insurerers while allowing them to sell it to everyone else at a reduced price https://www.goodrx.com/blog/humira-generic-availability-how-to-save/.

Humboldtianum on November 25th, 2019 at 12:17 UTC »

This study shows just how imperative it is for America to drastically change its healthcare system so that money doesn’t stand in the way of helping people survive as well as encouraging its people to be healthier so that these problems come up less often.